Jiangxi Rimag Group's Subsidiary to Acquire 18% Equity Interest in Financial Solutions Services Company

MT Newswires Live2024-11-04

Jiangxi Rimag Group's (HKG:2522) subsidiary Rimag Health Management agreed to purchase registered capital of 3.3 million yuan representing 18% equity interest in Shanghai Ronggongshe Fanghou Technology from Gongqingcheng Fanghou No.1 Investment Partnership for 17.3 million yuan, a Friday Hong Kong bourse filing said.

The group will fund the acquisition with its internal financial resources.

The medical imaging solution services company plans to use the innovative financial service solutions of the target company together with its imaging solutions to expand its reach and coverage in the industry chain it belongs to.

Price (HKD): $2210.13, Change: $+13, Percent Change: +0.61%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment